The EGFR or PTEN alteration induces continuous stimulation of the PI3K/Akt/mTOR pathway and increases activated AKT levels in glioma cells, thereby leading to tumorigenesis and resistance to cancer therapy [48]. The gene discussed is MTOR; the disease is central nervous system cancer.